Greece

Gilead Sciences Hellas Μ.EPE

Ethnarhou Makariou & Moraitini 4, P.Faliro

Floor 2, Postal Code 17561, Athens

Greece

Phone: +30 210 89 30 100 +30 210 89 30 100

Fax: +30 210 96 18 260

Gilead Sciences is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

Gilead Hellas has been operating in Greece since December 1995. It was first established as NeXstar Pharmaceuticals Inc. and subsequently became Gilead Sciences Hellas M.EPE in 2001. Gilead’s office in Athens provides sales, marketing, regulatory and medical support for our products throughout Greece and the Middle East.

Read more about Transparency Reporting

Relationships with Patient Organizations

Gilead provided support for the following charitable organizations in 2020. The information is correct at the time of writing (June 2021). The information is subject to change and periodic updates. For a listing of previous years’ payments, click here.

Recipient Description of Activity Amount Funded €
Ελληνική Ομοσπονδία Καρκίνου – ΕΛΛ.Ο.Κ. / Hellenic Cancer Federation ELLOK Consultancy service fee - Honoraria 260.40
Ελληνική Ομοσπονδία Καρκίνου – ΕΛΛ.Ο.Κ. / Hellenic Cancer Federation ELLOK Sponsorship to support the 4th Annual Congress of the Hellenic Federation of Cancer 9300
Ηλιαχτίδα / Iliahtida Grant for the support of people with special needs and paraplegic 2000
Αρχέγονο Κύτταρο Αίματος - AKA / Association Arxegono Kyttaro Aimatos Grant supporting activities for Bone Marrow Donation 2000
Ένωση Ασθενών Ελλάδας / Greek Patients Association Sponsorship of 9th Panhellenic Patients in Power Virtual Conference, Athens, 18-19/11/2020 8680
Ένωση Ασθενών Ελλάδας / Greek Patients Association Grant for conducting a study on patient access to care before Covid and after 2700
Ένωση Ασθενών Ελλάδας / Greek Patients Association Grant to the NGO Greek Patients Association supporting 12 interactive workshops for empowering Patient Groups 4000
Ένωση Ασθενών Ελλάδας / Greek Patients Association Grant supporting a 1 Day Scientific Event for Patient Rights 6000
Ένωση Ασθενών Ελλάδας / Greek Patients Association Grant through Gilead CARES fund Program 12646
Θετική Φωνή / Positive Voice Grant supporting "U=U" campaign 5000
Θετική Φωνή / Positive Voice Grant supporting "Me and HIV " campaign 9000
Θετική Φωνή / Positive Voice Grant for HIV campaigns (printing material and TV spots) and diagnostic Tests 20000
Θετική Φωνή / Positive Voice Grant through Gilead CARES fund Program 50596.89
Πανελλήνια Ομοσπονδία Συλλόγων Ασθενών, Γονέων, Κηδεμόνων και Φίλων Παιδιών με Ρευματικά Νοσήματα «ΡΕΥΜΑΖΉΝ» Grant for the creation of an RA video campaign for disease awareness 2000
Σύλλογος Ασθενών Ήπατος Ελλάδος «Προμηθέας» / Hellenic Liver Patients Association "Prometheus" Grant for HCV Campaign in the Greek Correctional Facilities for both staff and inmates 12000
Σύλλογος Ασθενών Ήπατος Ελλάδος «Προμηθέας» / Hellenic Liver Patients Association "Prometheus" Grant to support a COVID-19 awareness & prevention program on 10 Greek prisons 8000
Σύλλογος Ασθενών Ήπατος Ελλάδος «Προμηθέας» / Hellenic Liver Patients Association "Prometheus" Grant to support vulnerable groups due to COVID-19 2000
Σύλλογος Ασθενών Ήπατος Ελλάδος «Προμηθέας» / Hellenic Liver Patients Association "Prometheus" Grant through Gilead CARES fund Program 4984
Σύλλογος Ασθενών Ήπατος Ελλάδος «Προμηθέας» / Hellenic Liver Patients Association "Prometheus" Sponsorship supporting the conference "Confronting Inequalities in Health: Hepatitis C and People Who Use Drugs in Northern Greece” 10000
Θετική Φωνή / Positive Voice Sponsorship Travel expenses for participation 525.76
Σύλλογος Ασθενών Ήπατος Ελλάδος «Προμηθέας» / Hellenic Liver Patients Association "Prometheus" Consultancy fee for participation in Advisory Board Discussion 316.82

This page is intended for visitors outside of the United States.